| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BHVN | Common Shares | Options Exercise | $202K | +3.75K | +38.58% | $53.76* | 13.5K | Jan 19, 2022 | Direct | F1 |
| transaction | BHVN | Common Shares | Options Exercise | $62.2K | +1.92K | +14.25% | $32.42* | 15.4K | Jan 19, 2022 | Direct | F1 |
| transaction | BHVN | Common Shares | Sale | -$367K | -3.2K | -20.77% | $114.93* | 12.2K | Jan 19, 2022 | Direct | F1, F2 |
| transaction | BHVN | Common Shares | Sale | -$250K | -2.16K | -17.71% | $116.02* | 10K | Jan 19, 2022 | Direct | F1, F3 |
| transaction | BHVN | Common Shares | Sale | -$59K | -500 | -4.98% | $118.05* | 9.54K | Jan 19, 2022 | Direct | F1, F4 |
| transaction | BHVN | Common Shares | Sale | -$420K | -3.52K | -36.92% | $119.37* | 6.02K | Jan 19, 2022 | Direct | F1, F5 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BHVN | Employee Stock Option (right to buy) | Options Exercise | $0 | -3.75K | -45.45% | $0.00 | 4.5K | Jan 19, 2022 | Common Shares | 3.75K | $53.76 | Direct | F1, F6 |
| transaction | BHVN | Employee Stock Option (right to buy) | Options Exercise | $0 | -1.92K | -40.04% | $0.00 | 2.88K | Jan 19, 2022 | Common Shares | 1.92K | $32.42 | Direct | F1, F7 |
| Id | Content |
|---|---|
| F1 | These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.30 - $115.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.39 - $116.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. |
| F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.55 - $118.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. |
| F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.84 - $119.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. |
| F6 | The shares underlying this option vest in four equal installments on December 5, 2019, 2020, 2021 and 2022, subject to the reporting person's continued service with the issuer at each vesting date. |
| F7 | The shares underlying this option vest in four equal installments on November 20, 2019, 2020, 2021 and 2022, subject to the reporting person's continued service with the issuer at each vesting date. |